CrushSCI.com
308.2Average days
325Median days
29Fastest days
696Longest days
3282025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

280 days

The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors

Authors
Rohit Jain; Shweta Tikoo; Carlos Márquez-Burgoa; Stephanie A. Gerhofer; Brendon Martinez; Mariagiovanna Barresi; Dörte Symmank; Minoo Ghannadan; Barbara Öhler; Anna-Lena Höbler; Rafael de Freitas e Silva; Dirk Baumjohann; Susanne Feil; Robert Feil; Sylvia Knapp; Philipp Starkl; Wilfried Ellmeier; Steffen Jung; Jürgen Pollheimer; Stuart T. Fraser; Wolfgang WeningerShow moreShow less
Affiliations
1. Department of Dermatology, Medical University of Vienna, Vienna, Austria; 2. Centenary Institute, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia; 3. Sydney Medical School, University of Sydney, Camperdown, Australia; 4. Interfakultäres Institut für Biochemie (IFIB), Universität Tübingen, Tübingen, Germany; 5. Department of Obstetrics and Gynecology, Reproductive Biology Unit, Maternal–Fetal Immunology Group, Medical University of Vienna, Vienna, Austria; 6. Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Vienna, Austria; 7. Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Bonn, Germany; 8. Research Division of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; 9. Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel; 10. School of Medical Sciences, University of Sydney, Sydney, Australia; 11. University of Sydney Nano Institute, University of Sydney, Sydney, AustraliaShow moreShow less
Source PDF DOI Publisher page
281 days

A CD4-lineage erythro–myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

Authors
Shweta Tikoo; Rohit Jain; Brendon Martinez; Renhua Song; Matthias Wielscher; Carlos Márquez-Burgoa; Anastasiya Hladik; Simone Rizzetto; Lisa E. Shaw; Minoo Ghannadan; Stephanie A. Gerhofer; Andrew J. Mitchell; Maria Elizabeth Torres-Pacheco; Fabio Luciani; Matthias Farlik; Justin J. L. Wong; Sylvia Knapp; Philipp Starkl; Stuart T. Fraser; Steffen Jung; Wolfgang WeningerShow moreShow less
Affiliations
1. Department of Dermatology, Medical University of Vienna, Vienna, Austria; 2. Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 3. Sydney Medical School, The University of Sydney, Sydney, Australia; 4. Research Division of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; 5. School of Biomedical Sciences, University of New South Wales, Sydney, Australia; 6. Department of Chemical and Biomolecular Engineering, Materials Characterization and Fabrication Platform, University of Melbourne, Melbourne, Australia; 7. School of Medical Sciences, University of Sydney, Sydney, Australia; 8. University of Sydney Nano Institute, University of Sydney, Sydney, Australia; 9. Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, IsraelShow moreShow less
Source PDF DOI Publisher page
73 days

Cytokine circuits in CNS homeostasis and disease

Authors
Burkhard Becher; Donatella De Feo; Melanie GreterShow moreShow less
Affiliations
1. Institute of Experimental Immunology, University of Zurich, Zurich, SwitzerlandShow moreShow less
Source PDF DOI Publisher page
361 days

Serine protease inhibitor A3 is a soluble SIRPα ligand that suppresses inflammation and antitumor immunity

Authors
Yufei Hou; Lei Huang; Chunhui Jin; Xiaolong Li; Yongxing Chen; Liguang Sun; Feng Wang; Yong Zhang; Ying Wang; Meijuan Zou; Qina Xu; Zicheng Wang; Tao Jin; Naicui Zhai; Fei Xu; Wentao Liu; Yong-Guang YangShow moreShow less
Affiliations
1. Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China; 2. National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Jilin University, Changchun, China; 3. International Center of Future Science, Jilin University, Changchun, China; 4. Department of Pathology, The First Hospital of Jilin University, Changchun, China; 5. Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China; 6. Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, Changchun, ChinaShow moreShow less
Source PDF DOI Publisher page
464 days

IL-2-producing T FH cells sustain T reg cell homeostasis and immune tolerance in the gut

Authors
Shivangi Dave; Holly Bachus; Nathan Santiago; Audrey Meloun; Margery Smelkinson; Jeremy B. Foote; Thomas Hill; Christopher Fucile; Alexander F. Rosenberg; André Ballesteros-TatoShow moreShow less
Affiliations
1. The Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA; 2. Biological Imaging, Research Technology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA; 3. Department of Microbiology, The University of Alabama at Birmingham, Birmingham, USA; 4. Collaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA; 5. Department of Biomedical Informatics and Data Science, The University of Alabama at Birmingham, Birmingham, USAShow moreShow less
Source PDF DOI Publisher page
497 days

A single-cell atlas of human neutrophils reveals neutrophil heterogeneity across health and disease

Authors
Hong Zheng; Evan Maestri; Andrew R. Moore; Ananthakrishnan Ganesan; Jeanna Enriquez; Verónica Durán; Shirit Einav; Tom van der Poll; Hjalmar R. Bouma; Mihir R. Atreya; Philip A. Efron; Lyle L. Moldawer; Jonathan Sevransky; David W. Wright; Ignacio Martin-Loeches; Thomas Karvunidis; Jeremiah Hinson; David N. Hager; Richard E. Rothman; Evangelos J. Giamarellos-Bourboulis; Timothy E. Sweeney; Angela J. Rogers; Saurabh Gombar; Manoj V. Maddali; Jonathan H. Chen; Nigam Shah; Purvesh KhatriShow moreShow less
Affiliations
1. Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, USA; 2. Division of Computational Medicine, Department of Medicine, School of Medicine, Stanford University, Stanford, USA; 3. Stanford Immunology Program, School of Medicine, Stanford University, Stanford, USA; 4. Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, USA; 5. Department of Microbiology and Immunology, Stanford University, Stanford, USA; 6. Chan Zuckerberg Biohub, San Francisco, USA; 7. Department of Medicine, Stanford University, Stanford, USA; 8. Center of Infection and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 9. Division of Infectious Diseases, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 10. Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 11. Department of Acute Care, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 12. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 13. Division of Critical Care Medicine, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, USA; 14. Sepsis and Critical Illness Research Center and the SPIES Consortium, University of Florida College of Medicine, Gainesville, USA; 15. Division of Pulmonary, Allergy, Critical Care and Sleep and Emory Critical Care Center, Emory University, Atlanta, USA; 16. Department of Emergency Medicine, Emory University, Atlanta, USA; 17. Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James’s Hospital, Dublin, Ireland; 18. School of Medicine, Trinity College Dublin, Dublin, Ireland; 19. 1st Department of Internal Medicine, Faculty of Medicine, Teaching Hospital and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic; 20. Department of Emergency Medicine, The Johns Hopkins University, Baltimore, USA; 21. Danaher Diagnostics, Washington DC, USA; 22. Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University, Baltimore, USA; 23. 4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece; 24. Hellenic Institute for the Study of Sepsis, Athens, Greece; 25. Inflammatix Inc, Sunnyvale, USA; 26. Atropos Health, New York, USA; 27. Division of Pulmonary and Critical Care Medicine, Piedmont Healthcare, Atlanta, USA; 28. Division of Hospital Medicine, Stanford University School of Medicine, Stanford, USA; 29. Clinical Excellence Research Center, Stanford School of Medicine, Stanford, USA; 30. Technology and Digital Solutions, Stanford Healthcare, Palo Alto, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does NATURE IMMUNOLOGY take to review a manuscript?

As of 2026-11-18, CrushSCI has 21 complete review records for NATURE IMMUNOLOGY. The fastest paper went from submission to acceptance in 29 days (Human lungs maintain tissue-resident memory T cells against a broad spectrum of pathogens, received 2026-05-13, accepted 2026-06-11); the slowest took 696 days. The average is 308.2 days and the median is 325 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.